Wanlong Wu

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Emergency Department

Rheumatoid Arthritis

Peritoneal Dialysis

Top Venues

Therapeutic advances in musculoskeletal disease

European journal of nuclear medicine and molecular imaging

Modern rheumatology

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Wanlong Wu, Jinju Chen, Linling Zhu, Yaping Sha, Kaiwen Wang, Jiangfeng Zhao, Chunhua Ye, Shuang Ye
Janus kinase inhibitor for anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis. The British journal of dermatology (2023)
Jia Li, Weijun Wei, Wenwen Xu, Wanlong Wu, Jianjun Liu, Shuang Ye
[ 68 Ga]Ga-FAPI-04 and [ 18 F]FDG PET/ CT in a patient with MDA5 dermatomyositis. European journal of nuclear medicine and molecular imaging (2023)
Shuangjun He, Yuhong Zhou, Chenyu Fan, Jun Ma, Yi Chen, Wanlong Wu, Xingyu Zhang
Differences in sex- and Age-Associated Mortality in Patients with anti-MDA5 Positive Dermatomyositis. Modern rheumatology (2022)
Wanlong Wu, Jun Ma, Yuhong Zhou, Chao Tang, Feng Zhao, Fangfang Sun, Wenwen Xu, Jie Chen, Shuang Ye, Yi Chen
Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score. Therapeutic advances in musculoskeletal disease 11 (2019)